Answers are grounded in this paper and cite their sources.
This "Anti-Obesity Medications and Investigational Agents: An Obesity Medicine Association Clinical Practice Statement 2022" is one of a series of OMA CPSs designed to assist clinicians in the care of patients with pre-obesity/obesity.
No takes yet. Share an insight, caveat, or question.
Bays et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: